The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of treatment response to immunotherapy in melanoma patients with pathogenic mutations of NRAS, BRAF, CDKN2A and P53.
 
Thomas DeLeon
No Relationships to Disclose
 
Benjamin Kipp
No Relationships to Disclose
 
Blake Langlais
No Relationships to Disclose
 
Thomas Flotte
No Relationships to Disclose
 
Jennifer Winters
No Relationships to Disclose
 
Heidi E. Kosiorek
No Relationships to Disclose
 
Richard Wayne Joseph
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Genoptix; Nektar
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Merck; Roche/Genentech (Inst); X4 Pharma (Inst)
 
Svetomir Markovic
Research Funding - Celgene; Novartis
 
Roxana Stefania Dronca
Research Funding - Merck Sharp & Dohme (Inst)
Other Relationship - Elsevier
 
Matthew Stephen Block
No Relationships to Disclose
 
Robert R. McWilliams
Consulting or Advisory Role - Merrimack (Inst)
Research Funding - Aduro Biotech (Inst); Genentech (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Lisa A. Kottschade
Consulting or Advisory Role - Merck (Inst); Novartis
 
Mitesh J. Borad
No Relationships to Disclose
 
Kandelaria M. Rumilla
No Relationships to Disclose
 
Jesse S Voss
No Relationships to Disclose
 
Alan H. Bryce
No Relationships to Disclose